查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1459780

血浆分离市场（产品类型：免疫球蛋白、凝血因子浓缩物、白蛋白、蛋白酶抑制剂和其他血浆产品）- 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Plasma Fractionation Market (Product Type: Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Other Plasma Products) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 194 Pages | 商品交期: 2-10个工作天内

价格

血浆分馏市场 - 报告范围

TMR 关于全球血浆分馏市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球血浆分馏市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。该报告也提供了2023年至2031年全球血浆分离市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解血浆分馏市场。

市场概况
2022年市场价​​值 241 亿美元
2031 年市场价值 426 亿美元
CAGR 6.7%

该报告深入研究了全球血浆分馏市场的竞争格局。全球血浆分离市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球血浆分馏市场参与者的属性。

表内容

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：血浆分馏市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031 年血浆分馏市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 关键技术/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：血浆分馏市场分析与预测：依产品类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2017-2031
    • 免疫球蛋白
      • 静脉注射免疫球蛋白
      • 皮下注射免疫球蛋白
    • 凝血因子浓缩物
      • 因子VIII
      • 因子IX
      • 因子XIII
      • 凝血酶原复合物浓缩物
      • 血管性血友病因子 (VWF)
      • 纤维蛋白原浓缩物
    • 白蛋白
    • 蛋白酶抑制剂
    • 其他血浆产品
  • 市场吸引力分析：依产品类型，

第 7 章：血浆分馏市场分析与预测：按应用

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 神经病学
    • 免疫学
    • 血液学
    • 重症监护
    • 肺科
    • 其他的
  • 市场吸引力分析：按应用

第 8 章：血浆分馏市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院和诊所
    • 临床研究实验室
    • 学术机构
  • 市场吸引力分析：按应用

第 9 章：血浆分馏市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美血浆分馏市场分析与预测

第 11 章：欧洲血浆分馏市场分析与预测

第 12 章：亚太地区血浆分馏市场分析与预测

第 13 章：拉丁美洲血浆分馏市场分析与预测

第 14 章：中东和非洲血浆分馏市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（按级别和规模公司）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • CSL Limited
    • Takeda Pharmaceutical Company
    • Sanquin
    • Biotest AG
    • GRIFOLS
    • Baxter International Inc.
    • Kedrion
    • Octapharma AG
    • Taibang Biological Group Co., Ltd
Product Code: TMRGL48600

Plasma Fractionation Market - Scope of Report

TMR's report on the global plasma fractionation market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global plasma fractionation market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global plasma fractionation market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the plasma fractionation market.

Market Snapshot
Market Value in 2022US$ 24.1 Bn
Market Value in 2031US$ 42.6 Bn
CAGR6.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global plasma fractionation market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global plasma fractionation market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global plasma fractionation market.

The report delves into the competitive landscape of the global plasma fractionation market. Key players operating in the global plasma fractionation market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global plasma fractionation market profiled in this report.

Key Questions Answered in Global plasma fractionation Market Report:

  • What is the sales/revenue generated by plasma fractionation across all regions during the forecast period?
  • What are the opportunities in the global plasma fractionation market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Plasma Fractionation Market - Research Objectives and Research Approach

The comprehensive report on the global plasma fractionation market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global plasma fractionation market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global plasma fractionation market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Plasma Fractionation Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology, Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Plasma Fractionation Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology, /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Plasma Fractionation Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Immunoglobulin
      • 6.3.1.1. Intravenous Immunoglobulin
      • 6.3.1.2. Subcutaneous Immunoglobulin
    • 6.3.2. Coagulation Factor Concentrates
      • 6.3.2.1. Factor VIII
      • 6.3.2.2. Factor IX
      • 6.3.2.3. Factor XIII
      • 6.3.2.4. Prothrombin Complex Concentrates
      • 6.3.2.5. Von Willebrand Factor (VWF)
      • 6.3.2.6. Fibrinogen Concentrates
    • 6.3.3. Albumin
    • 6.3.4. Protease Inhibitors
    • 6.3.5. Other Plasma Products
  • 6.4. Market Attractiveness Analysis, by Product Type,

7. Plasma Fractionation Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Neurology
    • 7.3.2. Immunology
    • 7.3.3. Hematology
    • 7.3.4. Critical Care
    • 7.3.5. Pulmonology
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Plasma Fractionation Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals and Clinics
    • 8.3.2. Clinical Research Laboratories
    • 8.3.3. Academic Institutes
  • 8.4. Market Attractiveness Analysis, by Application

9. Plasma Fractionation Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Plasma Fractionation Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2017-2031
    • 10.3.1. Immunoglobulin
      • 10.3.1.1. Intravenous Immunoglobulin
      • 10.3.1.2. Subcutaneous Immunoglobulin
    • 10.3.2. Coagulation Factor Concentrates
      • 10.3.2.1. Factor VIII
      • 10.3.2.2. Factor IX
      • 10.3.2.3. Factor XIII
      • 10.3.2.4. Prothrombin Complex Concentrates
      • 10.3.2.5. Von Willebrand Factor (VWF)
      • 10.3.2.6. Fibrinogen Concentrates
    • 10.3.3. Albumin
    • 10.3.4. Protease Inhibitors
    • 10.3.5. Other Plasma Products
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Neurology
    • 10.4.2. Immunology
    • 10.4.3. Hematology
    • 10.4.4. Critical Care
    • 10.4.5. Pulmonology
    • 10.4.6. Others
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Hospitals and Clinics
    • 10.5.2. Clinical Research Laboratories
    • 10.5.3. Academic Institutes
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type,
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Plasma Fractionation Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2017-2031
    • 11.3.1. Immunoglobulin
      • 11.3.1.1. Intravenous Immunoglobulin
      • 11.3.1.2. Subcutaneous Immunoglobulin
    • 11.3.2. Coagulation Factor Concentrates
      • 11.3.2.1. Factor VIII
      • 11.3.2.2. Factor IX
      • 11.3.2.3. Factor XIII
      • 11.3.2.4. Prothrombin Complex Concentrates
      • 11.3.2.5. Von Willebrand Factor (VWF)
      • 11.3.2.6. Fibrinogen Concentrates
    • 11.3.3. Albumin
    • 11.3.4. Protease Inhibitors
    • 11.3.5. Other Plasma Products
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Neurology
    • 11.4.2. Immunology
    • 11.4.3. Hematology
    • 11.4.4. Critical Care
    • 11.4.5. Pulmonology
    • 11.4.6. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Clinical Research Laboratories
    • 11.5.3. Academic Institutes
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Plasma Fractionation Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2017-2031
    • 12.3.1. Immunoglobulin
      • 12.3.1.1. Intravenous Immunoglobulin
      • 12.3.1.2. Subcutaneous Immunoglobulin
    • 12.3.2. Coagulation Factor Concentrates
      • 12.3.2.1. Factor VIII
      • 12.3.2.2. Factor IX
      • 12.3.2.3. Factor XIII
      • 12.3.2.4. Prothrombin Complex Concentrates
      • 12.3.2.5. Von Willebrand Factor (VWF)
      • 12.3.2.6. Fibrinogen Concentrates
    • 12.3.3. Albumin
    • 12.3.4. Protease Inhibitors
    • 12.3.5. Other Plasma Products
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Neurology
    • 12.4.2. Immunology
    • 12.4.3. Hematology
    • 12.4.4. Critical Care
    • 12.4.5. Pulmonology
    • 12.4.6. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Clinical Research Laboratories
    • 12.5.3. Academic Institutes
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type,
    • 12.7.2. By Application
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Plasma Fractionation Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product Type, 2017-2031
    • 13.3.1. Immunoglobulin
      • 13.3.1.1. Intravenous Immunoglobulin
      • 13.3.1.2. Subcutaneous Immunoglobulin
    • 13.3.2. Coagulation Factor Concentrates
      • 13.3.2.1. Factor VIII
      • 13.3.2.2. Factor IX
      • 13.3.2.3. Factor XIII
      • 13.3.2.4. Prothrombin Complex Concentrates
      • 13.3.2.5. Von Willebrand Factor (VWF)
      • 13.3.2.6. Fibrinogen Concentrates
    • 13.3.3. Albumin
    • 13.3.4. Protease Inhibitors
    • 13.3.5. Other Plasma Products
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Neurology
    • 13.4.2. Immunology
    • 13.4.3. Hematology
    • 13.4.4. Critical Care
    • 13.4.5. Pulmonology
    • 13.4.6. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Clinical Research Laboratories
    • 13.5.3. Academic Institutes
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type,
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Plasma Fractionation Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product Type, 2017-2031
    • 14.3.1. Immunoglobulin
      • 14.3.1.1. Intravenous Immunoglobulin
      • 14.3.1.2. Subcutaneous Immunoglobulin
    • 14.3.2. Coagulation Factor Concentrates
      • 14.3.2.1. Factor VIII
      • 14.3.2.2. Factor IX
      • 14.3.2.3. Factor XIII
      • 14.3.2.4. Prothrombin Complex Concentrates
      • 14.3.2.5. Von Willebrand Factor (VWF)
      • 14.3.2.6. Fibrinogen Concentrates
    • 14.3.3. Albumin
    • 14.3.4. Protease Inhibitors
    • 14.3.5. Other Plasma Products
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Neurology
    • 14.4.2. Immunology
    • 14.4.3. Hematology
    • 14.4.4. Critical Care
    • 14.4.5. Pulmonology
    • 14.4.6. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Clinical Research Laboratories
    • 14.5.3. Academic Institutes
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type,
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. CSL Limited
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology, Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Takeda Pharmaceutical Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology, Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Sanquin
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology, Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Biotest AG
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology, Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. GRIFOLS
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology, Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Baxter International Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology, Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Kedrion
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology, Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Octapharma AG
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology, Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Taibang Biological Group Co., Ltd
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Technology, Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview

List of Tables

  • Table 01: Plasma Fractionation Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Plasma Fractionation Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Plasma Fractionation Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Plasma Fractionation Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Plasma Fractionation Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Plasma Fractionation Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 07: North America Plasma Fractionation Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Plasma Fractionation Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Plasma Fractionation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Plasma Fractionation Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 11: Europe Plasma Fractionation Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Plasma Fractionation Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Plasma Fractionation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Plasma Fractionation Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Asia Pacific Plasma Fractionation Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Plasma Fractionation Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Plasma Fractionation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Plasma Fractionation Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Latin America Plasma Fractionation Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Plasma Fractionation Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Plasma Fractionation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Plasma Fractionation Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Middle East & Africa Plasma Fractionation Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Plasma Fractionation Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Plasma Fractionation Market Size (US$ Mn) and Distribution (%), by Region, 2017-2031
  • Figure 02: Plasma Fractionation Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 03: Plasma Fractionation Market Value Share, by Product Type, 2022
  • Figure 04: Plasma Fractionation Market Revenue (US$ Mn), by Application, 2022
  • Figure 05: Plasma Fractionation Market Value Share, by Application, 2022
  • Figure 06: Plasma Fractionation Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Plasma Fractionation Market Value Share, by End-user, 2022
  • Figure 08: Plasma Fractionation Market Value Share, by Region, 2022
  • Figure 09: Plasma Fractionation Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 10: Plasma Fractionation Market Value Share Analysis, by Product Type, 2017-2031
  • Figure 11: Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 12: Plasma Fractionation Market Value Share Analysis, by Application, 2017-2031
  • Figure 13: Plasma Fractionation Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 14: Plasma Fractionation Market Value Share Analysis, by End-user, 2017-2031
  • Figure 15: Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 16: Plasma Fractionation Market Value Share Analysis, by Region, 2017-2031
  • Figure 17: Plasma Fractionation Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 18: North America Plasma Fractionation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Plasma Fractionation Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 20: North America Plasma Fractionation Market Value Share Analysis, by Country, 2017-2031
  • Figure 21: North America Plasma Fractionation Market Value Share Analysis, by Product Type, 2017-2031
  • Figure 22: North America Plasma Fractionation Market Value Share Analysis, by Application, 2017-2031
  • Figure 23: North America Plasma Fractionation Market Value Share Analysis, by End-user, 2017-2031
  • Figure 24: North America Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 25: North America Plasma Fractionation Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 26:North America Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 27: Europe Plasma Fractionation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Plasma Fractionation Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 29: Europe Plasma Fractionation Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 30: Europe Plasma Fractionation Market Value Share Analysis, by Product Type, 2017-2031
  • Figure 31: Europe Plasma Fractionation Market Value Share Analysis, by Application, 2017-2031
  • Figure 32: Europe Plasma Fractionation Market Value Share Analysis, by End-user, 2017-2031
  • Figure 33: Europe Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 34: Europe Plasma Fractionation Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: Europe Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 36: Asia Pacific Plasma Fractionation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Plasma Fractionation Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 38: Asia Pacific Plasma Fractionation Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 39: Asia Pacific Plasma Fractionation Market Value Share Analysis, by Product Type, 2017-2031
  • Figure 40: Asia Pacific Plasma Fractionation Market Value Share Analysis, by Application, 2017-2031
  • Figure 41: Asia Pacific Plasma Fractionation Market Value Share Analysis, by End-user, 2017-2031
  • Figure 42: Asia Pacific Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 43: Asia Pacific Plasma Fractionation Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 44: Asia Pacific Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 45: Latin America Plasma Fractionation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Plasma Fractionation Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 47: Latin America Plasma Fractionation Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 48: Latin America Plasma Fractionation Market Value Share Analysis, by Product Type, 2017-2031
  • Figure 49: Latin America Plasma Fractionation Market Value Share Analysis, by Application, 2017-2031
  • Figure 50: Latin America Plasma Fractionation Market Value Share Analysis, by End-user, 2017-2031
  • Figure 51: Latin America Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 52: Latin America Plasma Fractionation Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 53: Latin America Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 54: Middle East & Africa Plasma Fractionation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Plasma Fractionation Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 56: Middle East & Africa Plasma Fractionation Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 57: Middle East & Africa Plasma Fractionation Market Value Share Analysis, by Product Type, 2017-2031
  • Figure 58: Middle East & Africa Plasma Fractionation Market Value Share Analysis, by Application, 2017-2031
  • Figure 59: Middle East & Africa Plasma Fractionation Market Value Share Analysis, by End-user, 2017-2031
  • Figure 60: Middle East & Africa Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 61: Middle East & Africa Plasma Fractionation Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 62: Middle East & Africa Plasma Fractionation Market Attractiveness Analysis, by Product Type, 2023-2031